CEL-SCI closes $2.5 million offering of 2.5 million shares at $1.00 per share
CEL-SCI sold 2,500,000 common shares at $1.00 per share in a best-efforts offering through placement agent ThinkEquity, which closed on June 16, 2026, for gross proceeds of $2.5 million before fees and expenses. The company plans to use the net proceeds for development of Multikine, general corporate purposes and working capital. Existing shareholders will own a larger share of the company after the new shares are issued.
Key points
- 2,500,000 shares sold at $1.00 per share; gross proceeds of $2.5 million before placement fees and expenses
- Placement agent cash fee of 7.0% of gross proceeds, plus reimbursement of agent expenses of up to $67,000
- Company agreed not to issue additional shares or securities for 30 days from June 16, 2026, subject to exceptions
- Directors and officers agreed to a 45-day lock-up from June 14, 2026, subject to exceptions
The filing
Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 16, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.